Verisk Analytics Vs. Bright Minds Biosciences Industry Stock Comparison

Buy

52

VRSK
Verisk Analytics

Last Price:

$273.62

Seasonality Move:

3.1%

Sell

25

DRUG
Bright Minds Biosciences

Last Price:

$40.90

Seasonality Move:

-32.13%

Buy

52

Verisk Analytics (VRSK) is a Buy

Is Verisk Analytics a Buy, Sell or Hold?

The current Verisk Analytics [VRSK] share price is $275.43. The Score for VRSK is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
VRSK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

25

Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

The current Bright Minds Biosciences [DRUG] share price is $36.02. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VRSK Stock Price Chart

What is Verisk Analytics's stock price today?

The Verisk Analytics share price today is $275.43

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRSK is experiencing slight selling pressure.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

The Bright Minds Biosciences share price today is $36.02

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.

VRSK Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-2.13	Sell
Relative Strength Index (14 RSI):	36.86	Sell
Chaikin Money Flow:	-67512	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(277.41 - 290.71)	Sell
Bollinger Bands (100):	(265.96 - 283.52)	Buy

DRUG Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.28	Sell
Relative Strength Index (14 RSI):	43.81	Sell
Chaikin Money Flow:	1144	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(37.05 - 42.15)	Sell
Bollinger Bands (100):	(2.35 - 43.51)	Buy

VRSK Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	276.82	Sell
20-day SMA:	281.68	Sell
50-day SMA:	280.83	Sell
200-day SMA:	263.17	Buy
8-day EMA:	277.36	Sell
20-day EMA:	280.15	Sell
50-day EMA:	279.81	Sell
200-day EMA:	265.79	Buy

DRUG Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	38.37	Sell
20-day SMA:	39.18	Sell
50-day SMA:	42.07	Sell
200-day SMA:	12.03	Buy
8-day EMA:	38.08	Sell
20-day EMA:	38.79	Sell
50-day EMA:	35.67	Buy
200-day EMA:	17.98	Buy

Verisk Analytics Earnings Growth & VRSK Earnings Dates

Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $0.83 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Verisk Analytics Technical Analysis

	Dec 17	Dec 18	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31
	Dec
	17	18	19	20	23	24	26	27	30	31
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

	Dec 17	Dec 18	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31
	Dec
	17	18	19	20	23	24	26	27	30	31
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):